Zhejiang Jianfeng Group Company Ltd (600668):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Zhejiang Jianfeng Group Company Ltd (600668) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9302
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zhejiang Jianfeng Group Company Ltd (Jianfeng) is a diversified company. The company operates in the business of manufacturing cement, pharmaceuticals, health products, telecommunication and cables. It offers cement products that includes composite, ordinary, and slag Portland cement products. Jianfeng’s pharmaceutical products includes aspartic acid amlodipine tablets for hypertension; paroxetine hydrochloride tablets for various types of anxieties related with depression; vinegar acid chloride Finn zyban products for symptoms caused by osteoarthritis and rheumatoid arthritis; spray vial products for severe herpes zoster patients; sodium hyaluronate eye drops for dry eyes; and others. Jianfeng’s offers cable products comprising BV line common insulated and household electric wires; HYA series, which are copper core, solid polyolefin insulation block, and communications cables; RVV series that are cable mains; and SYWV-75 series products that are physical foaming cables. The company offers health products such as boiling Jade Kim tea bags, grape seed extract soft capsules, bomb sugar, Tianfu capsules, vitamin E nutritional capsules, bone Thai capsules, goodnight capsules, Sangge tea, lyophilized Tianma pieces, and broken fungus spore powder. It also offers warehousing and logistics services. Jianfeng is headquartered in Jinhua, China.

Zhejiang Jianfeng Group Company Ltd (600668) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Zhejiang Jianfeng To Form Joint Venture With Shanghai-Based Biotechnology Company 10
Debt Offering 11
Zhejiang Jianfeng to Raise USD48.8 Million in Second Tranche of Private Placement of Bonds 11
Zhejiang Jianfeng Group Completes Private Placement Of Notes Due 2013 For US$32 Million 12
Acquisition 13
Zhejiang Jianfeng Plans to Acquire 50.7% Stake in China-Based Biotech Company 13
Zhejiang Jianfeng to Acquire 95% Stake in Nexchem Pharma 14
Zhejiang Jianfeng Group Company Ltd – Key Competitors 15
Zhejiang Jianfeng Group Company Ltd – Key Employees 16
Zhejiang Jianfeng Group Company Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jianfeng Group Company Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zhejiang Jianfeng To Form Joint Venture With Shanghai-Based Biotechnology Company 10
Zhejiang Jianfeng to Raise USD48.8 Million in Second Tranche of Private Placement of Bonds 11
Zhejiang Jianfeng Group Completes Private Placement Of Notes Due 2013 For US$32 Million 12
Zhejiang Jianfeng Plans to Acquire 50.7% Stake in China-Based Biotech Company 13
Zhejiang Jianfeng to Acquire 95% Stake in Nexchem Pharma 14
Zhejiang Jianfeng Group Company Ltd, Key Competitors 15
Zhejiang Jianfeng Group Company Ltd, Key Employees 16
Zhejiang Jianfeng Group Company Ltd, Subsidiaries 17

List of Figures
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Zhejiang Jianfeng Group Company Ltd (600668):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Perstorp Holding AB:企業の戦略的SWOT分析
    Perstorp Holding AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • PUMA SE:企業の戦略・SWOT・財務情報
    PUMA SE - Strategy, SWOT and Corporate Finance Report Summary PUMA SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Elavon, Inc.:企業の戦略・SWOT・財務情報
    Elavon, Inc. - Strategy, SWOT and Corporate Finance Report Summary Elavon, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cypark Resources Berhad (CYPARK):企業の財務・戦略的SWOT分析
    Summary Cypark Resources Berhad (CRB) is a clean technology company that offers environmental engineering services. The company offers engineering and technology services on transforming dump sites to an economic and environmental boon. Its services include environmental remediation, integrated wast …
  • F. Hoffmann-La Roche Ltd (ROG):企業の財務・戦略的SWOT分析
    F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Qatar Petroleum:企業の戦略的SWOT分析
    Qatar Petroleum - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • Associated Petroleum Products Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Associated Petroleum Products Inc (APP), a subsidiary of World Fuel Services Corp is an oil and gas company that offers petroleum products. The company provides products such as commercial fuel, aviation fuel, fuels, heating oil, lube oil, fuel additives, propane, marine lubricants and equip …
  • Celltrion Inc (068270):企業の財務・戦略的SWOT分析
    Celltrion Inc (068270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Chugach Electric Association, Inc.:発電所・企業SWOT分析
    Chugach Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • Carlsberg A/S:企業の戦略・SWOT・財務情報
    Carlsberg A/S - Strategy, SWOT and Corporate Finance Report Summary Carlsberg A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Arix Bioscience PLC (ARIX)-製薬・医療分野:企業M&A・提携分析
    Summary Arix Bioscience PLC (Arix Bioscience), formerly Arix Bioscience Ltd, is a healthcare and life science company. It offers financing and operational and strategic direction for the companies to support their businesses. The company’s expertise spans in various areas which include academic scie …
  • Vital Therapies Inc (VTL)-医療機器分野:企業M&A・提携分析
    Summary Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute l …
  • Savior Lifetec Corp (4167):製薬・医療:M&Aディール及び事業提携情報
    Summary Savior Lifetec Corp (SLC) is an injectable manufacturer and distributor. The company offers active pharmaceutical ingredients (APIs) and finished dosage formulations. It provides sterile crystallization and aseptic processing of sterile powder. SLC offers carbapenem products, which include i …
  • R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析
    R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NKT AS (NKT):企業の財務・戦略的SWOT分析
    NKT AS (NKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • SVOGL Oil Gas and Energy Ltd:企業の戦略的SWOT分析
    SVOGL Oil Gas and Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Nissin Foods Holdings Co Ltd (2897):企業の財務・戦略的SWOT分析
    Nissin Foods Holdings Co Ltd (2897) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Johnson Matthey PLC:企業の戦略・SWOT・財務情報
    Johnson Matthey PLC - Strategy, SWOT and Corporate Finance Report Summary Johnson Matthey PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vertu Motors Plc:企業のM&A・事業提携・投資動向
    Vertu Motors Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vertu Motors Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆